Swankinter's profile picture. Prof. US stock trader. My edge: macro, fundamental & technical analysis for high-probability setups. No hype, just discipline. Sharing my insights daily.

Brooks

@Swankinter

Prof. US stock trader. My edge: macro, fundamental & technical analysis for high-probability setups. No hype, just discipline. Sharing my insights daily.

Pinned

Today I shared my investment plan in my WhatsApp group. I've also prepared some high-quality stock recommendations for everyone. You can contact me via WhatsApp private message: wa.me/12346501290 Just send "stocks" and I'll add you as a friend. 📈 Get insider stock…

Swankinter's tweet image. Today I shared my investment plan in my WhatsApp group. I've also prepared some high-quality stock recommendations for everyone.

You can contact me via WhatsApp private message:

wa.me/12346501290 Just send "stocks" and I'll add you as a friend.

📈 Get insider stock…

🚨🚨🚨Today's Summary: $LPTX +366.29% 🚀🚀🚀 $SPRU +54.59% 🚀🚀🚀 $CMBM +35.56% 🚀🚀🚀 Congratulations to the 20 friends who followed us today and have already achieved substantial profits of $8,000 to $20,000 under our real-time guidance. We share high-performing…

Swankinter's tweet image. 🚨🚨🚨Today's Summary:

$LPTX +366.29%   🚀🚀🚀

$SPRU +54.59%     🚀🚀🚀

$CMBM +35.56%    🚀🚀🚀

Congratulations to the 20 friends who followed us today and have already achieved substantial profits of $8,000 to $20,000 under our real-time guidance.

We share high-performing…

💥Today's Summary: 💥 $SRDX +49.92% 💥 $ENGN +47.42% 💥 $MSPR +75.39% Congratulations to all our participants in this investment program! Each of you has earned between $5,000 and $15,000.💸💸💸 For those who missed today's opportunity, please stay tuned tomorrow! #Stocks

Swankinter's tweet image. 💥Today's Summary:

💥 $SRDX +49.92%

💥 $ENGN +47.42%

💥 $MSPR +75.39%

Congratulations to all our participants in this investment program! Each of you has earned between $5,000 and $15,000.💸💸💸

For those who missed today's opportunity, please stay tuned tomorrow!

#Stocks…

🚀 $SRDX soars nearly 50% in pre-market after a federal judge clears the way for its acquisition by private equity firm GTCR. The deal, valued at $627 million, offers shareholders $43 per share in cash. A major win for medtech! #MergerNews #Stocks

Swankinter's tweet image. 🚀 $SRDX soars nearly 50% in pre-market after a federal judge clears the way for its acquisition by private equity firm GTCR. The deal, valued at $627 million, offers shareholders $43 per share in cash. A major win for medtech! 
#MergerNews #Stocks

$ENGN is drawing buzz 🔥 as a clinical-stage biotech advancing next-gen gene therapies for bladder cancer. Its lead asset, detalimogene voraplasmid, targets patients unresponsive to BCG — a high-need group. With strong clinical potential, this could be a real game-changer in…

Swankinter's tweet image. $ENGN is drawing buzz 🔥 as a clinical-stage biotech advancing next-gen gene therapies for bladder cancer. Its lead asset, detalimogene voraplasmid, targets patients unresponsive to BCG — a high-need group. With strong clinical potential, this could be a real game-changer in…

🚀 $MSPR is soaring over 80% premarket! LifeWallet’s recent settlements are sparking a powerful rebound. Q1 recovery income jumped to $6M (vs. $3.5M YoY), with key obligations extended into 2025 and fresh liquidity strengthening the outlook. Upside momentum is heating up fast.…

Swankinter's tweet image. 🚀 $MSPR is soaring over 80% premarket!

LifeWallet’s recent settlements are sparking a powerful rebound.

Q1 recovery income jumped to $6M (vs. $3.5M YoY), with key 
obligations extended into 2025 and fresh liquidity strengthening the outlook.
Upside momentum is heating up fast.…

🔥🔥🔥Today's Briefing: $GOCT +119.03%🚀🚀🚀 $SELX +85.51%🚀🚀🚀 $GLTO +247.47%🚀🚀🚀 Today is a good day; those who followed our advice have reaped substantial profits.💸💸💸💸 Are you still watching from the sidelines? #Stocks #DayTrading #StockWatch

Swankinter's tweet image. 🔥🔥🔥Today's Briefing:

$GOCT +119.03%🚀🚀🚀

$SELX +85.51%🚀🚀🚀

$GLTO +247.47%🚀🚀🚀

Today is a good day; those who followed our advice have reaped substantial profits.💸💸💸💸

Are you still watching from the sidelines?

#Stocks #DayTrading #StockWatch

$FUBO Chart Update: Look at just $3.88, worth a shot. Looks like it's attempting to breakout in the linear and log scale charts. If so, can see $6's...

Swankinter's tweet image. $FUBO Chart Update:

Look at just $3.88, worth a shot. Looks like it's attempting to breakout in the linear and log scale charts.

If so, can see $6's...
Swankinter's tweet image. $FUBO Chart Update:

Look at just $3.88, worth a shot. Looks like it's attempting to breakout in the linear and log scale charts.

If so, can see $6's...

Breaking News: $PSNL shares surged 32% after its NeXT Personal test, used to monitor minimal residual disease (MRD) in breast cancer, received Medicare coverage. This significant milestone boosted the company's revenue expectations. #Biotechnology #Stocks

Swankinter's tweet image. Breaking News:  $PSNL shares surged 32% after its NeXT Personal test, used to monitor minimal residual disease (MRD) in breast cancer, received Medicare coverage. This significant milestone boosted the company's revenue expectations. 

#Biotechnology #Stocks

$SELX surges 55%+ after hours! 🚀 A powerful rebound marks a clear momentum shift, fueled by heavy volume and a tight micro-float setup. Traders are zeroing in fast. #Stocks #Momentum #Trading

Swankinter's tweet image. $SELX surges 55%+ after hours! 🚀 A powerful rebound marks a clear momentum shift, fueled by heavy volume and a tight micro-float setup. Traders are zeroing in fast. 

#Stocks #Momentum #Trading

🚨 BREAKING: $COGT surges 109% pre-market after its Phase 3 PEAK trial for Bezuclastinib in GIST met all primary endpoints! With FDA Breakthrough Therapy Designation and multiple pipeline catalysts ahead, analysts reaffirm a Strong Buy. 🚀 #Stocks #DayTrader #StockWatch

Swankinter's tweet image. 🚨 BREAKING: $COGT surges 109% pre-market after its Phase 3 PEAK trial for Bezuclastinib in GIST met all primary endpoints!

With FDA Breakthrough Therapy Designation and multiple pipeline catalysts ahead, analysts reaffirm a Strong Buy. 🚀

#Stocks #DayTrader #StockWatch

$GLTO surges 271% pre-market to $18.40 after closing at $4.95. The explosive move reflects renewed investor confidence in biotech catalysts and unusually strong liquidity inflows. #Biotech #StocksToWatch #MarketInsights

Swankinter's tweet image. $GLTO surges 271% pre-market to $18.40 after closing at $4.95.
The explosive move reflects renewed investor confidence in biotech catalysts and unusually strong liquidity inflows.

#Biotech #StocksToWatch #MarketInsights

United States Trends

Loading...

Something went wrong.


Something went wrong.